BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27680017)

  • 1. Should low-income countries invest in breast cancer screening?
    Gyawali B; Shimokata T; Honda K; Tsukuura H; Ando Y
    Cancer Causes Control; 2016 Nov; 27(11):1341-1345. PubMed ID: 27680017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a subsidised mammographic screening programme in Malaysia, a middle-income Asian country.
    Lee M; Mariapun S; Rajaram N; Teo SH; Yip CH
    BMC Public Health; 2017 Jan; 17(1):127. PubMed ID: 28129762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of breast cancer in countries with limited resources.
    Anderson BO; Braun S; Lim S; Smith RA; Taplin S; Thomas DB;
    Breast J; 2003; 9 Suppl 2():S51-9. PubMed ID: 12713497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunity for breast cancer screening in limited resource countries: a literature review and implications for Iran.
    Asadzadeh VF; Broeders MJ; Kiemeney LA; Verbeek AL
    Asian Pac J Cancer Prev; 2011; 12(10):2467-75. PubMed ID: 22320940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dutch digital breast cancer screening: implications for breast cancer care.
    Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
    Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward.
    Black E; Richmond R
    Global Health; 2019 Jan; 15(1):3. PubMed ID: 30621753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries.
    Al-Foheidi M; Al-Mansour MM; Ibrahim EM
    Med Oncol; 2013 Jun; 30(2):471. PubMed ID: 23420062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of the Norwegian breast cancer screening program.
    van Luijt PA; Heijnsdijk EA; de Koning HJ
    Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is mammography for breast cancer screening cost-effective in both Western and asian countries?: results of a systematic review.
    Yoo KB; Kwon JA; Cho E; Kang MH; Nam JM; Choi KS; Kim EK; Choi YJ; Park EC
    Asian Pac J Cancer Prev; 2013; 14(7):4141-9. PubMed ID: 23991967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2016 Nov; 13(11S):R81-R88. PubMed ID: 27814820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation.
    Yip CH; Smith RA; Anderson BO; Miller AB; Thomas DB; Ang ES; Caffarella RS; Corbex M; Kreps GL; McTiernan A;
    Cancer; 2008 Oct; 113(8 Suppl):2244-56. PubMed ID: 18837017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer screening in developing countries.
    Panieri E
    Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):283-90. PubMed ID: 22222136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of mammography intervention in insured very low-income women.
    Ahmed NU; Haber G; Semenya KA; Hargreaves MK
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1790-8. PubMed ID: 20587669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system.
    Teh YC; Tan GH; Taib NA; Rahmat K; Westerhout CJ; Fadzli F; See MH; Jamaris S; Yip CH
    BMC Cancer; 2015 May; 15():405. PubMed ID: 25972043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost utility analysis of mammography screening in Australia.
    Hall J; Gerard K; Salkeld G; Richardson J
    Soc Sci Med; 1992 May; 34(9):993-1004. PubMed ID: 1631612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding patient options, utilization patterns, and burdens associated with breast cancer screening.
    Harvey SC; Vegesna A; Mass S; Clarke J; Skoufalos A
    J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S3-9. PubMed ID: 25247383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness of an organized breast cancer screening program in Southern Brazil].
    Ribeiro RA; Caleffi M; Polanczyk CA
    Cad Saude Publica; 2013 Nov; 29 Suppl 1():S131-45. PubMed ID: 25402242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.